Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBV-TCR-T Cell Injection for EBV DNAemia After Allo-HSCT
NCT07368634Phase 2Recruiting
- Sponsor
- Daihong Liu
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of EBV-TCR-T cell injection in Epstein-Barr virus infection, sponsored by Daihong Liu. Started Jun 2025; status: recruiting.
02
Drugs
EBV-TCR-T cell injection
03
Conditions
Epstein-Barr virus infection
Beyond the preview
Go deeper on NCT07368634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368634.